Further research is needed to answer this critical question conclusively
Supplementary Table 2) before correcting for other factors
Drugs such as semaglutide are an important and valid weight management tool for those living with or at risk of type 2 diabetes, and people should be supported to find the approach that is most appropriate for them. In August, Novo Nordisk published the findings of its own five-year study on Wegovy, known as the Select trial
One such option is Mounjaro (tirzepatide), a once-weekly injectable medication that was originally approved for type 2 diabetes and is now FDA-approved for weight management in adults with obesity or overweight and at least one weight-related health condition
Advanced performance and weight lowering can occasionally disturb sleep patterns, which can further impede muscle recovery
It is not known if RYBELSUS will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people Do not use RYBELSUS if: you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) you have had a serious allergic reaction to semaglutide or any of the ingredients in RYBELSUS